Figure 2

Prognostic value of RBM3 expression in primary melanoma. Tumours with high (strong intensity) RBM3 expression had a significantly improved (A) recurrence free survival and (B) overall survival compared to tumours with low RBM3 expression (negative to moderate intensity).